Mentalab

Mentalab operates in the neurotechnology and research-equipment space, serving researchers who need mobile EEG and broader ExG measurements. Its Explore Pro system is described as a lightweight, research-grade amplifier, while the company’s product information emphasizes wireless streaming, high-resolution offline recording, motion sensing, configurable electrodes, and use in studies such as BCI, hyperscanning, sleep, and mobile brain-body research. Those features distinguish the offering by combining portability with options for both real-time data access and offline acquisition. Mentalab also describes a wireless synchronization suite with sub-millisecond accuracy and an open-source API with raw-data streaming, capabilities relevant to multi-device experiments and custom BCI workflows. The company is categorized across neuroscience, software, internet, and information technology, reflecting a blend of hardware and research software. Its documented position is therefore best characterized by its specialist research focus, modular system options, and integration of mobile recording and synchronization features rather than by an asserted market ranking.

Mentalab was founded in 2016 and has a recorded Seed financing dated Apr 2, 2019, with Data Pitch identified as the sole investor and no disclosed round amount. The next clearly dated milestone is the May 9, 2022 announcement of Mentalab Explore, a biosensor positioned for brain research. Company product information now describes Explore Pro and a broader set of capabilities spanning mobile EEG/ExG recording, wireless streaming, offline acquisition, motion sensing, synchronization, and software tools. The reported employee band is 1–10, and a hiring signal cites a working-student role in hardware production and assembly; without a dated posting or historical headcount series, the scale and timing of workforce growth remain unclear. The main identifiable inflection points are the 2019 seed round and the 2022 Explore announcement. Further assessment of momentum is limited by the absence of dated launch details for current products and disclosed operating or financial metrics.